Affiliations Boston Va Health care System, Boston, Massachusetts, United states of america, Cardio for Genomic Medication, Massachusetts General Medical, Harvard Medical College or university, Boston, Massachusetts, Usa, Program in Scientific and you will Inhabitants Genes, Wide Institute out-of MIT and you may Harvard, Cambridge, Massachusetts, Usa
Affiliations Corporal Michael Crescenz Virtual assistant Hospital, Philadelphia, Pennsylvania, Us, Agencies out-of Businesses, Perelman College regarding Medicine, University away from Pennsylvania, Philadelphia, Pennsylvania, United states of america
Associations Corporal Michael Crescenz Va Medical, Philadelphia, Pennsylvania, United states, Department from Treatments, Perelman School of Medicine, College or university from Pennsylvania, Philadelphia, Pennsylvania, Usa
Affiliations Virtual assistant Palo Alto Health care Program, Palo Alto, Ca, Us, Agencies of Treatments, Stanford College College out of Medication, Stanford, California, United states of america
Associations Va Palo Alto Health care Program, Palo Alto, California, United states of america, Service off Medicine, Stanford College School regarding Drug, Stanford, Ca, U . s .
Affiliations Institution of Medication, Perelman School out-of Treatments, College from Pennsylvania, Philadelphia, Pennsylvania, United states, Service regarding Family genes, Perelman University of Medicine, College or university off Pennsylvania, Philadelphia, Pennsylvania, Usa
Opportunities Conceptualization, Analysis curation, Specialized studies, Funding purchase, Studies, Strategy, Investment management, Information, Supervision, Visualization, Writing – brand spanking new write, Creating – opinion & editing
Associations Corporal Michael Crescenz Va Healthcare facility, Philadelphia, Pennsylvania, United states, Agencies out of Genetics, Perelman University off Drug, University of Pennsylvania, Philadelphia, Pennsylvania, United states, Agency out of Options Pharmacology and you will Translational Therapeutics, Perelman College away from Treatments, School out of Pennsylvania, Philadelphia, Pennsylvania, U . s ., Institute to own Translational Drug and you will Therapeutics, Perelman University from Medicine, College out-of Pennsylvania, Philadelphia, Pennsylvania, United states
- Kelsey E. Johnson,
- Katherine M. Siewert,
- Derek Klarin,
- Scott M. Damrauer,
- the Va Billion Experienced Program,
- Kyong-Mi Chang,
- Philip S. Tsao,
- Themistocles L. Assimes,
- Kara N. Maxwell,
History
Many epidemiological and you can hereditary studies have attempted to dictate if or not quantities of releasing lipids are associated with the risks of individuals cancer tumors, as well as cancer of the breast (BC). Yet not, it stays unsure if a causal matchmaking is obtainable between lipids and you will BC. If modification away from lipid membership in addition to quicker chance of BC, this could present a target getting disease cures. This research aimed to assess a prospective causal dating ranging from hereditary versions associated with plasma lipid faculties (high-occurrence lipoprotein, HDL; low-density lipoprotein, LDL; triglycerides, TGs) which have chance getting BC having fun with Mendelian randomization (MR).
Steps and you will conclusions
Data from genome-wide association studies in up to 215,551 participants from the Million Veteran Program (MVP) were used to construct genetic instruments for plasma lipid traits. The effect of these instruments on BC risk was evaluated using genetic data from the BCAC (Breast Cancer Association Consortium) based on 122,977 BC cases and 105,974 controls. Using MR, we observed that a 1-standard–deviation genetically determined increase in HDL levels is associated with an increased risk for all BCs (HDL: OR [odds ratio] = 1.08, 95% confidence interval [CI] = 1.04–1.13, P < 0.001). Multivariable MR analysis, which adjusted for the effects of LDL, TGs, body mass index (BMI), and age at menarche, corroborated this observation for HDL (OR = 1.06, 95% CI = 1.03–1.10, P = 4.9 ? 10 ?4 ) and also found a relationship between LDL and BC risk (OR = 1.03, 95% CI = 1.01–1.07, P = 0.02). We did not observe a difference in these relationships when stratified by breast tumor estrogen receptor (ER) status. We repeated this analysis using genetic variants independent of the leading association at core HDL pathway genes and found that these variants were also associated with risk for BCs (OR = 1.11, 95% CI = 1.06–1.16, P = 1.5 ? 10 ?6 ), including locus-specific associations at ABCA1 (ATP Binding Cassette Subfamily A Member 1), APOE-APOC1-APOC4-APOC2 (Apolipoproteins E, C1, C4, and C2), and CETP (Cholesteryl Ester Transfer Protein). In addition, we found evidence that genetic variation at the ABO locus is associated with both lipid levels and BC. Through multiple statistical approaches, we minimized and tested for the confounding effects of pleiotropy and population stratification on our analysis; however, the possible existence of residual pleiotropy and stratification remains a limitation of this study.